Found: 33
Select item for more details and to access through your institution.
Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care Setting.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1499, doi. 10.1007/s13300-019-0662-y
- By:
- Publication type:
- Article
The Potential Impact of the FreeStyle Libre Flash Glucose Monitoring System on Mental Well-Being and Treatment Satisfaction in Patients with Type 1 Diabetes: A Prospective Study.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1239, doi. 10.1007/s13300-019-0616-4
- By:
- Publication type:
- Article
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin's Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1509, doi. 10.1007/s13300-019-0640-4
- By:
- Publication type:
- Article
Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1453, doi. 10.1007/s13300-019-0658-7
- By:
- Publication type:
- Article
Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1487, doi. 10.1007/s13300-019-0656-9
- By:
- Publication type:
- Article
American Diabetes Association 2019 Conference Podcast With the Editor-in-Chief: What Are the Outcomes from ADA This Year and What Are the Future Developments in Diabetes?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Comment on "Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report" by Hsieh et al.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Response to 'Comment on "Excessive Sodium Bicarbonate Infusion May Result in Osmotic Demyelination Syndrome During Treatment of Diabetic Ketoacidosis: A Case Report" by Hsieh et al.'.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Prevalence of Diabetes and Prediabetes in Adults from a Third-Tier City in Eastern China: A Cross-Sectional Study.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1473, doi. 10.1007/s13300-019-0655-x
- By:
- Publication type:
- Article
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1535, doi. 10.1007/s13300-019-0654-y
- By:
- Publication type:
- Article
Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1423, doi. 10.1007/s13300-019-0650-2
- By:
- Publication type:
- Article
Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1381, doi. 10.1007/s13300-019-0647-x
- By:
- Publication type:
- Article
Clinical Outcomes of Transmetatarsal Amputation in Patients with Diabetic Foot Ulcers Treated without Revascularization.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1465, doi. 10.1007/s13300-019-0653-z
- By:
- Publication type:
- Article
Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1531, doi. 10.1007/s13300-019-0649-8
- By:
- Publication type:
- Article
Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1407, doi. 10.1007/s13300-019-0648-9
- By:
- Publication type:
- Article
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2).
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1435, doi. 10.1007/s13300-019-0646-y
- By:
- Publication type:
- Article
Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1391, doi. 10.1007/s13300-019-0645-z
- By:
- Publication type:
- Article
Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1369, doi. 10.1007/s13300-019-0643-1
- By:
- Publication type:
- Article
GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1205, doi. 10.1007/s13300-019-0642-2
- By:
- Publication type:
- Article
Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1219, doi. 10.1007/s13300-019-0641-3
- By:
- Publication type:
- Article
Association of OSAHS Hypoxia Indicators with Early Renal Injury and Serum Fibroblast Growth Factor 21 in Obese Type 2 Diabetic Patients.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1357, doi. 10.1007/s13300-019-0639-x
- By:
- Publication type:
- Article
Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1181, doi. 10.1007/s13300-019-0637-z
- By:
- Publication type:
- Article
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1323, doi. 10.1007/s13300-019-0636-0
- By:
- Publication type:
- Article
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1347, doi. 10.1007/s13300-019-0635-1
- By:
- Publication type:
- Article
Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1337, doi. 10.1007/s13300-019-0634-2
- By:
- Publication type:
- Article
Maturity Onset Diabetes of the Young is Not Necessarily Associated with Autosomal Inheritance: Case Description of a De Novo HFN1A Mutation.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1543, doi. 10.1007/s13300-019-0633-3
- By:
- Publication type:
- Article
Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1523, doi. 10.1007/s13300-019-0632-4
- By:
- Publication type:
- Article
Effect of Intravitreal Anti-Vascular Growth Factor Agents With or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1283, doi. 10.1007/s13300-019-0631-5
- By:
- Publication type:
- Article
Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1297, doi. 10.1007/s13300-019-0630-6
- By:
- Publication type:
- Article
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1189, doi. 10.1007/s13300-019-0629-z
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1271, doi. 10.1007/s13300-019-0628-0
- By:
- Publication type:
- Article
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1249, doi. 10.1007/s13300-019-0627-1
- By:
- Publication type:
- Article